Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bystander immune cytolysis.

Lawrence D Petz1

  • 1University of California Los Angeles (UCLA) Medical Center, Los Angeles, CA, USA. lpetz@stemcyte.com

Transfusion Medicine Reviews
|March 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.

The lancet. HIV·2015
Same author

Progress toward curing HIV infection with hematopoietic cell transplantation.

Stem cells and cloning : advances and applications·2015
Same author

Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2014
Same author

George Garratty, PhD, FIBMS, FRCPath, 1935-2014.

Transfusion·2014
Same author

Hematopoietic cell transplantation with cord blood for cure of HIV infections.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2012
Same author

Cell recovery comparison between plasma depletion/reduction- and red cell reduction-processing of umbilical cord blood.

Cytotherapy·2011
Same journal

A Reply to "Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine".

Transfusion medicine reviews·2026
Same journal

Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine.

Transfusion medicine reviews·2026
Same journal

Trust Over Knowledge: Rethinking Donor Iron Supplementation Strategies in Modern Blood Services-Authors' reply.

Transfusion medicine reviews·2026
Same journal

The Effect of Stress Ball and Music on Anxiety, Distress, and Pain Levels During Platelet Apheresis Donation: Randomized Controlled Trial.

Transfusion medicine reviews·2026
Same journal

Therapeutic Plateletpheresis for Thrombocytosis: Critical Analytic Reviews and Original Multicenter Experience.

Transfusion medicine reviews·2026
Same journal

ABO Matching for Platelets: When Surrogates Lead and Clinical Evidence Lags.

Transfusion medicine reviews·2026
See all related articles

A third category of immune blood cell destruction, bystander immune cytolysis, occurs when immune reactions harm cells not targeted by the immune response. This phenomenon can mimic autoimmune disease, impacting clinical diagnosis and treatment.

Area of Science:

  • Immunology
  • Hematology

Background:

  • Traditional understanding of immune-mediated blood cell destruction includes alloimmune and autoimmune lysis.
  • A novel category, bystander immune cytolysis, is increasingly recognized in clinical settings.

Observation:

  • Immune responses to exogenous antigens can trigger temporary autoantibody development.
  • This leads to the destruction of autologous cells, mimicking autoimmune conditions.
  • Cells can also be lysed by antibodies not directed against their intrinsic antigens.

Findings:

  • Bystander immune cytolysis involves immune reactions where cells act as "innocent bystanders."
  • This mechanism explains immune destruction of autologous cells in specific clinical scenarios.
  • Alloimmune reactions can also lead to the lysis of bystander cells.

Related Experiment Videos

Implications:

  • Physicians must differentiate bystander immune cytolysis from true autoimmune disease.
  • Awareness of this mechanism is crucial for accurate diagnosis and patient management.
  • Understanding bystander cytolysis refines our comprehension of immune-mediated hematologic disorders.